News

2 Weeks of Personalized Rehab Offered in New Wellness Program

A just-launched wellness program is offering a two-week, inpatient rehabilitation experience tailored to the needs of people with Parkinson’s disease. Its goal is to maximize patients’ independence. The program is being offered by the Hackensack Meridian JFK Johnson Rehabilitation Institute, in Edison, New Jersey. “In our new program, patients…

MyoExo Sensors Remotely Measure Muscle Strain, Bulging

Scientists have created a set of sensors that can help measure muscle strain and bulging while integrated in a wearable device, such as clothes, a feature that may be of use for people with Parkinson’s disease. The sensors could be used to remotely monitor disease progression, quantify the effects, and…

Parkinson’s Awareness Month Begins With #FutureofPD Campaign

To mark the start of Parkinson’s Awareness Month, the Parkinson’s Foundation has kicked off its #FutureofPD Campaign, an initiative to call attention to the progressive neurodegenerative disorder and highlight what can be done to create a better future for the Parkinson’s disease community. “Parkinson’s disease affects nearly…

Phase 2a Study of IkT-148009 Expected to Start Soon

Inhibikase expects to begin a Phase 2a study of IkT-148009, its investigational therapy for Parkinson’s disease, in the second quarter of 2022, with dosing of the first patient being subject to clearance by the U.S. Food and Drug Administration (FDA). Last year, the company began dosing IkT-148009…

#AAN2022 – ND0612 Shows Good Safety Profile After 4+ Years

ND0612, an investigational formulation of carbidopa/levodopa delivered continuously via a subcutaneous pump, was generally well-tolerated for more than four years of treatment in a Phase 2 clinical trial of Parkinson’s patients, new data show. Findings reveal that the vast majority of adverse events (side effects) reported in…

Azilect as Add-on to Requip May Improve Sleep Quality

Azilect (rasagiline) as an add-on therapy to Requip (ropinrole) improved sleep, reduced the need for sleep medications, and enhanced quality of life in a small group of people with Parkinson’s disease, a study suggested. These findings support more extensive studies to confirm the sleep-related benefits of Azilect,…